Research Focus

Former Employee. Molecular Pharmacology Program; Research Associate

Recent additions – View all

1. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer

   Journal Article

   Sepp-Lorenzino, L.; Tjaden, G.; Moasser, M. M.; Timaul, N.; Ma, Z.; Kohl, N. E.; Gibbs, J. B.; Oliff, A.; Rosen, N.; Scher, H. I.
   Prostate Cancer and Prostatic Diseases (2001)

   Fulltext@MSK | Save
2. Farnesyl: Protein transferase inhibitors (FTIs): Potential chemotypes for the management of human prostate cancer

   Meeting Abstract

   Sepp-Lorenzino, L.; Tjaden, G.; Timaul-Holmes, M.; Moasser, M.; Chou, J. L.; Balog, A.; Su, D. S.; Danishefsky, S. J.; Kohl, N.; Oliff, A.; more...
   Proceedings of the American Association for Cancer Research Annual Meeting (1998)

   Fulltext@MSK | Save
3. Prostate cancer cell lines exhibit varied sensitivity to ansamycin-induced apoptosis

   Meeting Abstract

   Tjaden, G.; Scher, H.; Rosen, N.
   Proceedings of the American Association for Cancer Research Annual Meeting (1997)

   Fulltext@MSK | Save